Bibliographic Details
| Title: |
Sacituzumab Govitecan plus Pembrolizumab for Advanced Triple-Negative Breast Cancer. |
| Authors: |
Tolaney, S. M.1 sara_tolaney@dfci.harvard.edu, de Azambuja, E.2, Kalinsky, K.3, Loi, S.4, Kim, S.-B.5, Yam, C.6, Rapoport, B.7,8, Im, S.-A.9, Pistilli, B.10, Mchayleh, W.11, Cescon, D. W.12, Watanabe, J.13, Bañuelas, M. A. L.14, Freitas-Junior, R.15, Bofill, J. Salvador16, Afshari, M.17, Gary, D.17, Wang, L.17, Lai, C.17, Schmid, P.18 |
| Source: |
New England Journal of Medicine. 1/22/2026, Vol. 394 Issue 4, p354-366. 13p. |
| Database: |
Academic Search Ultimate |
